HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors

4′-C-Methyl-2′-Deoxyadenosine and 4′-C-Ethyl-2′-Deoxyadenosine Inhibit HIV-1 Replication

(2011) B. Christie Vu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations

(2011) Shiro Ibe et al.   Future Microbiology

Drug resistance mutations in patients infected with HIV-2 living in Spain

(2011) A. Trevino et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes

(2011) Vivek Jain et al.   JOURNAL OF INFECTIOUS DISEASES

Retroviral reverse transcriptases

(2010) Alon Herschhorn et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Effects of Mutations F61A and A62V in the Fingers Subdomain of HIV-1 Reverse Transcriptase on the Translocational Equilibrium

(2010) Brian Scarth et al.   JOURNAL OF MOLECULAR BIOLOGY

Structural basis of HIV-1 resistance to AZT by excision

(2010) Xiongying Tu et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

(2009) M. L. Ntemgwa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reverse transcriptase in motion: Conformational dynamics of enzyme–substrate interactions

(2009) Matthias Götte et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West Africa

(2009) Geoffrey S. Gottlieb et al.   CLINICAL INFECTIOUS DISEASES

Thymidine Analogue Resistance Suppression by V75I of HIV-1 Reverse Transcriptase

(2009) Tania Matamoros et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants

(2009) S. Jallow et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antiretroviral Drug Resistance in HIV‐2: Three Amino Acid Changes Are Sufficient for Classwide Nucleoside Analogue Resistance

(2009) Robert A. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

(2009) M. C. Puertas et al.   JOURNAL OF VIROLOGY

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

(2008) M. L. Ntemgwa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

(2008) Jean Ruelle et al.   BMC INFECTIOUS DISEASES

Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition

(2008) Stefan G. Sarafianos et al.   JOURNAL OF MOLECULAR BIOLOGY

In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine

(2008) R. Paredes et al.   JOURNAL OF VIROLOGY

HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision

(2008) K. A. Delviks-Frankenberry et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase

(2008) Luis Menéndez-Arias   VIRUS RESEARCH

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo

(2008) Javier Martinez-Picado et al.   VIRUS RESEARCH